Quaker Houghton · NYSE:KWR
Quaker Houghton — Quaker Chemical — Q1 2025 Earnings Presentation
15 slides from Quaker Houghton's earnings presentation, May 1, 2025
Slide 1: Quaker Houghton First Quarter 2025 Results Investor Conference Call
Quaker Houghton First Quarter 2025 Results Investor Conference Call
Slide 2: Regulation G and Forward-Looking Statements
Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”). Management believes that an analysis of this data is meaningful to investors because it provides insight with respect to ongoing operating results of the Company a
Slide 3: Non-GAAP Financial Information
The information included in this presentation includes non-GAAP (unaudited) financial information that includes EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, taxes on income before equity in net income of associated companies- adjusted, non-GA
Slide 4: Speakers
Joe Berquist Chief Executive Officer, President Tom Coler Executive Vice President, Chief Financial Officer Robert T. Traub Senior Vice President, General Counsel & Corporate Secretary Jeffrey Schnell Vice President, Investor Relations ©2025 Quaker Houghton. All Rights Reserved 4 Speakers
Slide 5: Q1'25 Highlights
Q1’25 Highlights © 2025 Quaker Houghton. All Rights Reserved $443m Net Sales $69m Adjusted EBITDA1 5 $1.58 Non-GAAP Earnings per Diluted Share1 1.9x Net Debt Leverage1,3 1 This is a non-GAAP measure, refer to the reconciliations of our non-GAAP measures to their most comparable GAAP measures provide
Slide 6: Financial Snapshot
©2025 Quaker Houghton. All Rights Reserved 6 Financial Snapshot (Unaudited; Dollars in millions, unless otherwise noted) (1) Certain amounts may not calculate due to rounding (2) These are non-GAAP measures. Refer to the reconciliations of our non-GAAP measures to their most comparable GAAP measures
Slide 7: Total Company Volume Trend
Sales volumes in Q1’25 declined compared to Q1’24 primarily due to a continuation of soft end market conditions and heightened uncertainty, partially offset by acquisitions Total Company Volume Trend1 (kilograms, in thousands) 7 ©2025 Quaker Houghton. All Rights Reserved Q1 2022 Q2 2022 Q3 2022 Q4 2
Slide 8: Adjusted EBITDA
©2025 Quaker Houghton. All Rights Reserved 8 Adjusted EBITDA1 (dollars in millions) Generated $69m of adjusted EBITDA in Q1’25, a decrease Y/Y reflecting soft end market activity, higher raw material costs and lower gross margins, partially offset by lower SG&A as we effectively managed our costs. 1
Slide 9: Leverage and Liquidity Update
• Total debt of $737 million • Cash and cash equivalents of $186 million • Net debt of $551 million • Leverage of 1.9x as of March 31, 20251 • Operating well within bank covenants ◦ Bank leverage of 1.8x as of March 31, 20252 ◦ Maximum permitted leverage of 4.0x2 • Healthy balance sheet and ample li
Slide 10: Appendix: Actual and Non-GAAP Results
Appendix Actual and Non-GAAP Results
Slide 11: Non-GAAP Operating Reconciliation
©2025 Quaker Houghton. All Rights Reserved 11 Non-GAAP Operating Reconciliation (Unaudited; Dollars in thousands, unless otherwise noted) Three Months Ended March 31, Non-GAAP Operating Income and Margin Reconciliations: 2025 2024 Operating income $ 27,624 $ 55,526 Restructuring and related charges,
Slide 12: Adjusted EBITDA Reconciliation
©2025 Quaker Houghton. All Rights Reserved 12 Adjusted EBITDA Reconciliation (Unaudited; Dollars in thousands, unless otherwise noted) EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin Reconciliations: Three Months Ended March 31, 2025 2024 Net income attributable to Quaker Chemical Corporation $ 12,9
Slide 13: Adjusted EBITDA Reconciliation (Annual)
©2025 Quaker Houghton. All Rights Reserved 13 Adjusted EBITDA Reconciliation (Unaudited; Dollars in thousands, unless otherwise noted) EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin Reconciliations: Twelve Months Ended December 31, 2024 2023 2022 2021 Net income (loss) attributable to Quaker Ch
Slide 14: Non-GAAP EPS Reconciliation
©2025 Quaker Houghton. All Rights Reserved 14 Non-GAAP EPS Reconciliation Three Months Ended March 31, Non-GAAP Earnings per Diluted Share Reconciliations: 2025 2024 GAAP earnings per diluted share attributable to Quaker Chemical Corporation common shareholders $ 0.73 $ 1.95 Equity income in a capti
Slide 15: Segment Performance
©2025 Quaker Houghton. All Rights Reserved 15 Segment Performance (Unaudited; Dollars in thousands, except per share amounts) Three Months Ended March 31, 2025 2024 Net sales Americas $ 213,711 $ 229,754 EMEA 129,278 138,422 Asia/Pacific 99,925 101,583 Total net sales $ 442,914 $ 469,759 Segment ope